Italia markets closed

FTSE MIB
35.398,82
-11,31(-0,03%)
Dow Jones
40.003,59
+134,21(+0,34%)
Nasdaq
16.685,97
-12,35(-0,07%)
Nikkei 225
38.787,38
-132,88(-0,34%)
Petrolio
80,00
+0,77(+0,97%)
Bitcoin EUR
61.415,34
+1.348,70(+2,25%)

Alcon Inc. (ALC.SW)

Swiss - Swiss Prezzo differito. Valuta in CHF.

Aggiungi a watchlist

80,08

-0,80

(-0,99%)

Alla chiusura: 05:30PM CEST

Capitalizzazione	39,499B
Beta (5 anni mensile)	0,68
Rapporto PE (ttm)	41,71
EPS (ttm)	1,92
Prossima data utili	13 mag 2024
Rendimento e dividendo (futuro)	0,24 (0,30%)
Data ex dividendo	14 mag 2024
Stima target 1A	84,73

Tutte

GlobeNewswire
Lifecore Biomedical Enters into $150.0 Million in New Financing, Repays its Outstanding Term Loans and Signs New Supply Agreement to Expand HA Fermentation Capacity with Existing Long-Term Customer
New $150 million credit arrangements include six-year credit agreement and equipment sale and leaseback to replace existing term loanCHASKA, Minn., May 22, 2023 (GLOBE NEWSWIRE) -- Lifecore Biomedical, Inc. (“Lifecore” or the “Company” Nasdaq: LFCR), a fully integrated contract development and manufacturing organization (“CDMO”), today announced that it has entered into a broad set of agreements with its long-term customer, Alcon (SIX/NYSE: ALC), which provides for the repayment of the Company’s